Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
XRAY · against 374 other Healthcare companies of similar size
Ranked #302 of 375 · scores higher than 18% of peers
Bars: peers in each 10-point band of the growth score51 peers with a growth score of 20–29, including XRAY · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | XRAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 376 reported | -3.0% | 6.5% | 22% | 33% | |
| Earnings per share growthHigher is better · 211 reported | Not reported | 8.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 367 reported | -2.1% | 7.8% | 20% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 302 | 10.4B CNY (≈$1.5B) | 22 | 42 | |
| 302 | 7.2B CNY (≈$1.0B) | 22 | 44 | |
| 302 | 7.0B CNY (≈$977M) | 22 | 39 | |
| 302 | 1.7B USD | 22 | 44 | |
| 302 | 1.9B USD | 22 | 38 | |
| 308 | 10.6B CNY (≈$1.5B) | 21 | 43 | |
| 308 | 1.43T KRW (≈$1.0B) | 21 | 55 | |
| 308 | 2.2B USD | 21 | 23 | |
| 311 | 9.6B CNY (≈$1.3B) | 20 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score